Theriva Biologics (NYSE:TOVX) filed a preliminary prospectus for offering of up to about 7.69M shares of common stock, together with warrants to purchase up to 7.69M shares of common stock. SEC Filing

More on Theriva Biologics

Theriva Biologics up on positive DSMC review in SYN-004 trial for transplant recipients Seeking Alpha's Quant Rating on Theriva Biologics Historical earnings data for Theriva Biologics Financial information for Theriva Biologics